Blue Shield of California has appointed Erin Brewer, former CFO of Lyft, to its Board of Directors. Brewer brings over 25 years of experience in finance, strategy, and operations across healthcare, technology, and financial services. Her expertise is expected to support Blue Shield's goals of making healthcare more affordable and improving service delivery. Brewer expressed enthusiasm for advancing Blue Shield's nonprofit mission and enhancing healthcare affordability for its members and communities.
Blue Shield of California's board appointment news comes with this market context from Pluang. For readers following the health sector, here is Pluang's snapshot as of Oct 15, 2026 22:11 WIB: Out of 150 US health stocks, 134 rose and 16 fell. Notable movers include ABEO at USD 4.71 with a +8.03% change and 54% sell order activity, Moderna (MRNA) at USD 241.97 with +6.92% and 83% buy order activity, and Inovio (INO) at USD 1.05 with +6.49% and 97% buy order activity.
The obesity treatment landscape is rapidly evolving with over 200 companies developing more than 200 pipeline drugs, including late-stage and early-stage clinical trials. Major pharmaceutical firms like Novo Nordisk and Eli Lilly are leading with inn...
Alice collaborated with Inflection AI and AI21 to demonstrate that NVIDIA Nemotron open models can be post-trained using real-world adversarial data to enhance AI safety and security without losing capability. Inflection AI improved conversational AI...
Stifel Nicolaus has reiterated a Buy rating for Accenture with a price target of $242, reflecting confidence in the company's strong recent stock performance and growth prospects. Accenture's shares rose 13.4% in the month leading up to October 15, 2...
Investment firm William Blair downgraded CCC Intelligent Solutions to Market Perform amid news of a $6.1 billion acquisition by a consortium led by GTCR and Elliott Investment Management. Shareholders will receive $7.75 per share, a premium over rece...
U.S. Bancorp reported third-quarter 2026 earnings per share of $1.34, exceeding analyst estimates of $1.32 and marking its fourth consecutive earnings beat. Revenue grew 8.8% year-over-year to $7.97 billion but fell just short of the $8.00 billion ex...
